State Street’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

State Street’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-48,934	Closed	-$275K	–	4920
2022 Q3	$275K	Hold	48,934	–	–	﹤0.01%	4002
2022 Q2	$212K	Sell	48,934 -152,635	-76%	-$868K	﹤0.01%	4171
2022 Q1	$2.35M	Buy	201,569 +38,241	+23%	+$455K	﹤0.01%	3500
2021 Q4	$2.98M	Buy	163,328 +622	+0.4%	+$7.89K	﹤0.01%	3494
2021 Q3	$1.93M	Buy	162,706 +22,599	+16%	+$329K	﹤0.01%	3625
2021 Q2	$2.41M	Buy	140,107 +32,074	+30%	+$610K	﹤0.01%	3515
2021 Q1	$1.98M	Sell	108,033 -2,923	-3%	-$61.3K	﹤0.01%	3445
2020 Q4	$2.09M	Buy	110,956 +8,824	+9%	+$190K	﹤0.01%	3356
2020 Q3	$2.16M	Buy	102,132 +6,161	+6%	+$144K	﹤0.01%	3169
2020 Q2	$2.77M	Buy	95,971 +1,518	+2%	+$45.7K	﹤0.01%	3051
2020 Q1	$3.31M	Buy	94,453 +52,023	+123%	+$1.68M	﹤0.01%	2824
2019 Q4	$1.04M	Buy	+42,430	New	+$745K	﹤0.01%	3399

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street's OYST Position: Q4 2022 in Review

State Street sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2022, closing a stake of 48,934 shares — an estimated $275K sold.

State Street first reported a position in OYST in Q4 2019 and held it in 12 quarters. The position peaked at $3.31M in Q1 2020. 53 funds tracked by Wall St. Rank hold OYST as of Q4 2022.

State Street reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
State Street sold 48,934 Oyster Point Pharma, Inc. Common Stock shares in Q4 2022, an estimated $275K.
State Street first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
State Street's Oyster Point Pharma, Inc. Common Stock position peaked at $3.31M in Q1 2020.
53 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2022.

Based on State Street's 13F filing for Q4 2022, filed 14 Feb 2023.